GL Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Imviva is a clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases.
BiotechDeep TechHealthtechMedical Devices
Jiangtao Ren(Chief Scientific Officer)Lu Han(Chief Executive Officer)Yajin Ni(Chief Technology Officer)Jan Davidson(Chief Medical Officer)
Co-investorsDecheng CapitalHillhouse CapitalShenzhen Capital Group
CertiK is a Web3 security platform that combines formal verification with smart contract audits, penetration testing, on-chain monitoring, AML/compliance tools, and incident response for blockchain projects, exchanges, and wallets.
Crypto & Web3CybersecuritySaaSNew York City, US
Sergey Gorbunov(Co-Founder)Alex Wilke(Co-Founder)Zhong Shao(Founder)inRonghui Gu(Founder)inProfessor Ronghui Gu(Founder)Professor Zhong Shao(Founder)
Co-investors10T FundCandaq Fintech GroupCoatue ManagementCoinbase VenturesContinue CapitalCyberport Hong Kong+17 more
XAG develops agricultural drones, ground rovers, autopilot consoles, smart fertigation systems, and farm management IoT products for precision farming and intelligent management of water, fertilizer, and pesticides.
AgTechAI & Machine LearningRobotics
Peng Bin(Founder)
Co-investorsSoftBank Vision FundBaiduBaidu CapitalBaidu VenturesSinovation VenturesSoftBank Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













